F7

Thorne Healthtech IncFRA Thorne Stock Report

Last reporting period 30 Jun, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

0.551

Micro

Exchange

XFRA - Deutsche Boerse AG

F7G.F Stock Analysis

F7

Uncovered

Thorne Healthtech Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

68/100

Moderate score

Market cap $B

0.551

Dividend yield

Shares outstanding

52.812 B

Thorne HealthTech, Inc. is a science-driven wellness company that is developing solutions and personalized approaches to health and well-being. Its brands, Thorne and Onegevity, provide insights and personalized data, products and services that help individuals take a proactive approach to maintaining their health over their lifetime. The Company by combining its multi-omics database, artificial intelligence (AI) and digital health content with its science-backed nutritional supplements deliver a total system for wellness. Its Thorne provides health tests, education, and products that support the optimization of health. The Company’s Onegevity combines AI with professional human assistance to map, integrate and understand the biological features that illustrate the state of an individuals' health. It offers health tests to generate personalized, molecular portraits for its customers. It is also focused on developing solutions to address the unmet needs relative to brain health.

View Section: Eyestock Rating